###begin article-title 0
Morphogenesis signaling components influence cell cycle regulation by cyclin dependent kinase
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
###xml 349 354 <span type="species:ncbi:4932">yeast</span>
The yeast cell cycle is largely controlled by the cyclin-dependent kinase (CDK) Cdc28. Recent evidence suggests that both CDK complex stability as well as function during mitosis is determined by precise regulation of Swe1, a CDK inhibitory kinase and cyclin binding partner. A model of mitotic progression has been provided by study of filamentous yeast. When facing nutrient-limited conditions, Ras2-mediated PKA and MAPK signaling cascades induce a switch from round to filamentous morphology resulting in delayed mitotic progression.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2 </italic>
To delineate how the dimorphic switch contributes to cell cycle regulation, temperature sensitive cdc28 mutants exhibiting constitutive filamentation were subjected to epistasis analyses with RAS2 signaling effectors. It was found that Swe1-mediated inhibitory tyrosine phosphorylation of Cdc28 during filamentous growth is in part mediated by Ras2 activation of PKA, but not Kss1-MAPK, signaling. This pathway is further influenced by Cks1, a conserved CDK-binding partner of elusive function with multiple proposed roles in CDK activation, transcriptional regulation and ubiquitin-mediated proteasome degradation.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 116 121 <span type="species:ncbi:4932">yeast</span>
The dynamic balance between Cks1- and Swe1-dependent regulation of Cdc28 and, thereby, the timing of mitosis during yeast dimorphism is regulated in part by Ras2/cAMP-mediated PKA signaling, a key pathway controlling filamentous growth.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast cell division is tightly coupled to morphology. Progression through mitosis activates an apical-isotropic switch in which polarized bud growth is redirected to produce round daughter cells [1]. Conversely, mitotic delay results in filamentous growth allowing spreading away from the colony center. Thus, filamentation may be elicited by mutations in mitotic regulators such as the cyclin-dependent kinase (CDK) Cdc28 or its mitotic cyclin binding partner Clb2 [2-4]. Cdc28/Clb2 complexes phosphorylate hundreds of effectors containing S/TP sites, preferably (S/T)PX(K/R), including mitotic spindle components, signaling proteins and other cell cycle regulators [5,6].
###end p 9
###begin p 10
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 405 410 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2 </italic>
###xml 462 473 462 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2-VAL19 </italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 947 952 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1 </italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1205 1210 1205 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8 </italic>
###xml 1256 1261 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFL1 </italic>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1394 1403 1394 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2-V19 </italic>
###xml 1415 1417 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
The switch from round to filamentous growth is stimulated physiologically by environmental conditions including low nitrogen availability or fusel alcohol exposure [7]. Although it has been hypothesized that these stimuli impinge on CDK and/or its regulators, no clear mechanism has emerged. Extracellular signals are conveyed through a member of the highly conserved RAS GTPase family, Ras2. Deletion of RAS2 diminishes filamentation, while the dominant allele RAS2-VAL19 induces constitutive pseudohyphal differentiation [2]. Ras2 activates both the Sterile (Ste) Mitogen-Activated Protein Kinase (MAPK) and the Protein Kinase A (PKA) - cAMP cascades [8]. The MAPK pathway involves sequential activation of the PAK kinase Ste20, the MAPKKK Ste11, the MAPKK Ste7 and the MAPK Kss1, culminating in the activation of the transcription factors Tec1 and Ste12 [9,10]. Accordingly, overproduction of Tec1 induces filamentation [11], while deletion of TEC1 decreases filament formation [12]. On the other hand, in the PKA pathway, the PKA subunit Tpk2 specifically activates filamentation by activation of the transcription factor Flo8 and inhibition of the transcriptional repressor Sfl1 [13,14]. Deletion of FLO8 diminishes filamentation, whereas deletion of SFL1 enhances filamentation [12]. Production of cAMP is opposed by phosphodiesterases Pde1 and Pde2 which when overexpressed reverse some RAS2-V19 phenotypes [15,16].
###end p 10
###begin p 11
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSL1 </italic>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 954 959 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSL1 </italic>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSL1 </italic>
###xml 1072 1077 1072 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8 </italic>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1</italic>
###xml 1117 1127 1117 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flo8 tec1 </italic>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
One possible target of Ras2 signaling may be the Wee kinase Swe1. Swe1 inhibits Cdc28-Clb2 activity at G2/M via phosphorylation of Cdc28 Tyr19 and a phosphorylation-independent mechanism [17]. Overexpression of Swe1 or stabilization of Swe1 delays mitosis and promotes cell elongation and hyperfilamentation [17-19]. Tyrosine-19 may make direct contact with ATP [20], and it is thought that phosphorylation and even binding by Swe1 impedes ATP utilization by Cdc28. In turn, initial Swe1 phosphorylation by Cdc28/Clb2 complexes stabilizes its interaction with Cdc28, potentiating further inhibition. Inhibition is alleviated by Mih1, a CDK tyrosine phosphatase, which reactivates Cdc28 to hyperphosphorylate Swe1 leading to its dissociation from CDK complexes [21]. Swe1 is also controlled by the Nim1 kinase Hsl1. Deletion of HSL1 results in increased Cdc28 tyrosine-19 phosphorylation [22] and enhanced filamentation [17,18], whereas overexpression of HSL1 leads to diminished Swe1 protein levels [23]. Further, deletion of HSL1 restores filamentation in the absence of FLO8 and to a lesser degree TEC1, but not in flo8 tec1 double mutants [18]. This suggests that PKA has greater specificity for Swe1 inhibition of Cdc28.
###end p 11
###begin p 12
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC20 </italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDE2 </italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BCY1 </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc16-1 </italic>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
PKA has also been shown to mediate Ras2 and glucose-dependent inhibition of the anaphase-promoting complex (APC) [24,25]. The APC is a ubiquitin-protein ligase complex that functions to target proteins for destruction by the proteasome [26]. Overexpression of both the APC-activator CDC20 as well as negative regulators of the PKA pathway PDE2 and BCY1 were found to suppress the temperature sensitivity of a cohesin mutant [27]. Further analysis showed that inhibition of PKA also suppressed temperature sensitivity of cdc16-1 mutant defective in APC function [27]. Together these studies indicate the possibility that PKA may negatively regulate the APC. Such a mechanism may further separate the role of PKA from Kss1-MAPK in the regulation of filamentous growth.
###end p 12
###begin p 13
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 240 256 240 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-Y18V, T19F</italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC20</italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cks1 </italic>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Importantly, Cdc28 is also intimately linked to APC activation. Cdc20-dependent APC activity during mitosis is positively regulated via phosphorylation by Cdc28 [28]. Reduced binding of Cdc20 to the APC has been observed in the presence of cdc28-Y18V, T19F, a mutant resistant to Swe1 mediated phosphorylation [28]. Further, the CDK subunit Cks1 is required for transcription of CDC20. The precise mechanism remains obscure but has been proposed to involve Cks1 recruitment of the proteasome to Cdc28 complexes [29]. Cks1 has been shown to physically interact with proteasome subunits [30]. Interestingly, while certain cks1 temperature-sensitive alleles confer G2/M delay [31], Clb cyclin-Cdc28 complexes do not require Cks1 for normal kinase activity [31,32].
###end p 13
###begin p 14
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
To further elucidate the pathway by which extracellular signals impinge on cell cycle, we screened for temperature sensitive cdc28 mutants that perform enhanced filamentous growth. A preponderance of the mutations localized to the binding region of Cks1. We examined the genetic interactions of these mutants with cell cycle regulators and Ras2 signaling components. Our results indicate that the PKA-cAMP pathway may be an additional signaling mechanism by which Swe1 inhibition of Cdc28 is affected. However, Swe1 function is downregulated by a mechanism requiring association of Cdc28 with Cks1.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
cdc28 mutants suggest Cks1 is a regulator of filamentation
###end title 16
###begin p 17
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28 </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRP1 </italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28</italic>
###xml 440 446 440 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 459 462 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS</italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
We hypothesized that constitutively filamentous cdc28 mutants, which experience growth arrest at elevated temperatures would be valuable tools to identify connections between cell cycle and extracellular signals. Therefore, a cdc28 shuffle strain was created in which homozygous replacement of CDC28 with TRP1 gene was covered by a URA3 marked plasmid harboring CDC28. Transformation of this strain with a library of degenerate-PCR derived cdc28 alleles on a HIS3 marked plasmid, followed by negative selection against URA3 allowed screening colonies for mutants exhibiting enhanced filamentous growth on low nitrogen media. Five hundred colonies were selected [3]. Secondary screening of these colonies for those that exhibited temperature sensitive growth at 35degreesC revealed 39 mutants with one to five amino acid substitutions.
###end p 17
###begin p 18
###xml 329 331 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 332 334 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 335 337 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 430 431 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 432 434 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 668 669 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 742 743 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1041 1042 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1245 1246 1238 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 411 416 <span type="species:ncbi:9606">human</span>
Cyclin-dependent kinase is a bi-lobed protein with an amino terminal domain composed primarily of beta-sheets and a larger carboxy-terminal domain containing several alpha-helices. Between these two domains lies the catalytic core, the opening of which is covered by the T-loop (activation loop) in the inactive monomeric state [20,33-35]. We have previously modeled Cdc28 based on the crystal structure of the human CDK2 enzyme [3,36]. Mapping the residues modified in the selected mutants on our model revealed that while some fell within the interior of the molecule, many were surface residues predicted to participate in binding to known essential partners (Fig. 1). Several mutations fell close to or within the ATP binding cleft (Fig. 1, green) and thus near Tyr19, the target of Swe1 mediated phosphorylation. Other mutations fell in the PSTAIRE helix involved in cyclin binding and catalytic function, or the activation loop, a domain involved in substrate recognition that includes Thr169, the target of Cak1 phosphorylation (Fig. 1, red). However, nearly one third of the alleles contained mutations that might impinge on Cdc28 interaction with Cks1 by altering contact residues, or residues underlying the Cks1 binding surface (Fig. 1, yellow and orange).
###end p 18
###begin p 19
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hyper-filamentous, temperature sensitive <italic>cdc28 </italic>mutants exhibit altered Cks1-binding region</bold>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 175 180 <span type="species:ncbi:9606">human</span>
Hyper-filamentous, temperature sensitive cdc28 mutants exhibit altered Cks1-binding region. The three-dimensional structure of Cdc28 was modeled from the crystal structure of human CDK2 [3]. Each allele is listed with amino acid substitutions color coded according to the functional region of the molecule in which it lies: yellow = Cks1 binding, orange = non-surface residues underlying the Cks1-binding domain, green = ATP-binding, red = cyclin-binding, white = uncharacterized structure function relationship, striped = ATP.
###end p 19
###begin p 20
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1</italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1</italic>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 491 503 491 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 507 519 507 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-N238D </italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1206 1207 1206 1207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1475 1476 1475 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
We were struck by the high number of mutations potentially affecting Cks1 binding, as this factor had yet to be directly linked to the apical-isotropic switch or filamentous differentiation. We examined if normal growth could be restored in these mutants by high copy CKS1. Indeed, 11 out of 15 alleles exhibited improved growth by CKS1 overexpression (Table 1). Of the 11 mutants suppressed by CKS1, four exhibited near wild type restoration of growth and morphology (1). The point mutants cdc28-E217V and cdc28-N238D were in this category suggesting that these alterations were less likely to directly affect additional partner associations. Although both mutations lie in the Cks1 binding region, co-crystal studies of the CDK2-Cks1 interface have demonstrated a direct contact only for the residue analogous to Cdc28 Glu217 with residues Glu63 and His94 in Cks1 [37]. Importantly, our bioinformatic analysis using algorithms designed by Chasman and Adams for assessment of the functional consequences of amino acid substitutions [38], indicated that mutation of residue E217 to valine should not otherwise affect the structure of monomeric Cdc28 (data not shown). E217 falls in the highly conserved GDSEID (214-219) motif, previously implicated in Cdc28 binding to Cks1 [39]. Mutations in residues 212, 213, and 215-218 were also identified by this screen, indicating that this domain of Cdc28 is particularly important for regulating morphological differentiation (Fig. 1).
###end p 20
###begin p 21
Genetic comparison of temperature sensitive alleles containing mutations in the Cks1 binding domain
###end p 21
###begin p 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28</italic>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28</italic>
###xml 330 334 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8</italic>
###xml 359 363 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1</italic>
HIS3-marked plasmids (pRS413) containing temperature sensitive cdc28 alleles were introduced into a CDC28 shuffle strain. Transformants were subjected to 5-FOA treatment to evict the wild type copy of CDC28 and assayed for growth at 25degreesC and 35degreesC. If growth of a given allele was significantly improved by deletion of FLO8 or by overexpression of CKS1, then suppression is indicated by "+". A sign of "-" indicates no change.
###end p 22
###begin p 23
###xml 44 55 44 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V</italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28 </italic>
###xml 115 126 115 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V</italic>
###xml 159 171 159 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
###xml 255 267 255 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 399 408 399 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 424 428 424 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1</sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 399 407 <span type="species:ncbi:4896">S. pombe</span>
To better study the genetic interactions of cdc28-E217V, we performed genomic replacement of endogenous CDC28 with cdc28-E217V. As expected, transformation of cdc28-E217V with high copy CKS1 similarly relieved mutant phenotypes as previously found in the cdc28-E217V shuffle strain (Fig. 2A). We also observed decreased pull-down of Cdc28-E217V compared to wild-type Cdc28 with beads coupled to the S. pombe Cks1 homolog p13Suc1, under conditions of saturating amounts of Cdc28 and Cdc28-E217V proteins (Fig. 2B). These data strongly suggest a loss of association of Cdc28 with its essential partner Cks1 as the basis for the temperature sensitivity in this mutant. Cdc28-E217V also showed normal Cdc28 protein abundance and levels of Clb2- associated histone H1 kinase activity at permissive and restrictive temperatures (data not shown), in accordance with previous reports indicating that Cks1 does not affect mitotic CDK kinase activity [32].
###end p 23
###begin p 24
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>cdc28-E217V </italic>cells exhibit specific genetic interactions with cell-cycle regulators</bold>
###xml 84 87 84 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAK1</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB2 </italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC28</italic>
###xml 288 291 288 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 294 299 294 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1 </sup>
###xml 371 383 371 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 448 451 442 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 491 508 485 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">clb2 cdc28-E217V </italic>
###xml 110 115 <span type="species:ncbi:4932">yeast</span>
###xml 322 327 <span type="species:ncbi:4932">yeast</span>
cdc28-E217V cells exhibit specific genetic interactions with cell-cycle regulators. A) Growth of cdc28 mutant yeast cells containing genomic substitution of E217V transformed with high-copy plasmids harboring CKS1, CAK1, CLN1, CLB2 or no insert, or a centromeric plasmid harboring CDC28. B) p13Suc1 beads-pull downs using yeast protein extract prepared from wild-type or cdc28-E217V at 30degreesC. Blots were probed with anti-PSTAIRE CDK antibody. C) Inviability and elongated morphology of clb2 cdc28-E217V double mutant segregants.
###end p 24
###begin p 25
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAK1 </italic>
###xml 234 246 234 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 459 471 459 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 503 515 503 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAK1 </italic>
###xml 674 686 674 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTC2 </italic>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTC3 </italic>
###xml 889 901 889 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 931 943 931 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 1057 1069 1057 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
However, we further questioned if the defects of this mutant were specifically attributable to its diminished interaction with Cks1. As a means to examine this possibility we tested overexpression of the CDK-activating kinase CAK1 in cdc28-E217V cells. Cak1 is an essential CDK activator that phosphorylates Cdc28 on Thr169 in the T loop to promote kinase activity, substrate accessibility and cyclin binding [40,41]. If Cak1 overexpression were to alleviate cdc28-E217V defects, it could indicate that cdc28-E217V harbors intrinsic defects in CDK function or in interaction with other binding partners or substrates. However, high copy CAK1 neither suppressed nor enhanced cdc28-E217V defects (Fig. 2A). Dephosphorylation of Thr169 has been shown to be likely mediated by phosphatases Ptc2 and Ptc3 [42]. We found that overexpression of PTC2 and PTC3 was similarly toxic to wild-type and cdc28-E217V cells (data not shown). Thus, cdc28-E217V phenotypes are not affected by alteration of activating phosphorylation of Cdc28. This further substantiates that cdc28-E217V defects are specific to interaction with Cks1.
###end p 25
###begin p 26
###xml 201 213 201 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB2 </italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLB2 </italic>
###xml 278 290 278 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 344 360 344 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V clb2</italic>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
###xml 673 685 673 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
Given the well-established roles of Cln1 and Clb2 cyclins at the G1/S and the G2/M transitions respectively, as well as their opposing effects on the apical-isotropic switch, we examined modulation of cdc28-E217V phenotypes by CLB2 and CLN1. CLB2 overexpression partly restored cdc28-E217V growth at semi-permissive temperature (Fig. 2A) while cdc28-E217V clb2 double mutant segregants were inviable, germinating to form only elongated, terminal buds (Fig. 2C). In turn, CLN1 overexpression diminished proliferation at semi-permissive temperature (Fig. 2A) while deletion of CLN1 partly restored growth (data not shown). These results further support that the phenotype of cdc28-E217V is due to delayed mitotic progression.
###end p 26
###begin title 27
Protein Kinase A pathway impinges on Cdc28
###end title 27
###begin p 28
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 118 130 118 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2 </italic>
###xml 241 253 241 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A,B</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8 </italic>
###xml 457 469 457 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C,D</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFL1 </italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1</italic>
###xml 624 636 624 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 663 668 663 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, C</xref>
###xml 756 768 756 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDE2</italic>
###xml 949 961 949 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
In filamentous growth signaling, Ras2 activates both the PKA pathway and the Kss1-MAPK cascade [43]. We questioned if cdc28-E217V phenotypes were dependent on Ras2 signaling. Deletion of RAS2 restored near wild-type growth and morphology to cdc28-E217V cells (Fig. 3A,B). Two transcriptional regulators, Flo8 and Sfl1, function as downstream effectors of the PKA pathway [13]. Deletion of FLO8 partially alleviated both the growth and morphology defects of cdc28-E217V (Fig. 3C,D), whereas deletion of SFL1 showed no effect (Fig. 4A). Deletion of TEC1, a transcription factor required for MAPK signaling, also did not alter cdc28-E217V growth or morphology (Fig. 4B, C). These results suggested that the Ras2-activated PKA pathway specifically impinged on cdc28-E217V through Flo8. Providing further confirmation of this connection we found that a high-copy plasmid harboring the cAMP phosphodiesterase PDE2, a negative regulator of PKA, suppressed cdc28-E217V defects (data not shown) [44,45].
###end p 28
###begin p 29
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ras2-mediated PKA pathway impinges on Cdc28</bold>
###xml 45 48 45 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 59 62 59 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 76 92 76 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V ras2</italic>
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras2 </italic>
###xml 165 168 159 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 179 182 173 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 196 213 190 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V flo8 </italic>
###xml 251 263 245 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 267 272 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flo8 </italic>
###xml 303 306 291 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E) </bold>
###xml 316 333 304 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V gcn4 </italic>
###xml 371 383 359 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 387 392 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcn4 </italic>
Ras2-mediated PKA pathway impinges on Cdc28. A) Growth and B) Morphology of cdc28-E217V ras2, wild-type, cdc28-E217V, or ras2 cells growing at 25, 30 or 35degreesC. C) Growth and D) morphology of cdc28-E217V flo8 double mutants compared to wild-type, cdc28-E217V and flo8 cells at 25, 30 or 35degreesC. E) Growth of cdc28-E217V gcn4 double mutants compared to wild-type, cdc28-E217V and gcn4 cells at 30degreesC and 35degreesC.
###end p 29
###begin p 30
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1 </italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFL1</italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>cdc28-E217V </italic>is not affected by deletion of <italic>TEC1 </italic>or <italic>SFL1</italic></bold>
###xml 57 60 57 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sfl1</italic>
###xml 87 99 87 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 111 128 111 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sfl1 cdc28-E217V </italic>
###xml 240 243 228 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 253 270 241 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V tec1 </italic>
###xml 308 320 296 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 324 329 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tec1 </italic>
###xml 357 360 339 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 382 387 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1 </italic>
###xml 404 416 386 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
cdc28-E217V is not affected by deletion of TEC1 or SFL1. A) Growth of wild type, sfl1, cdc28-E217V strains and sfl1 cdc28-E217V double mutants was examined using of 5-fold serial dilutions of saturated cultures at 30degreesC and 35degreesC B) Growth of cdc28-E217V tec1 double mutants compared to wild-type, cdc28-E217V and tec1 cells at 25 and 35degreesC. C) Effect of deletion of TEC1 on morphology of cdc28-E217V at 25, 30 or 35degreesC.
###end p 30
###begin p 31
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCN4 </italic>
###xml 273 285 273 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8 </italic>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
It has also been reported that the PKA pathway, but not the Kss1-MAPK cascade, may be required for activation of filamentation during amino acid starvation by the transcription factor Gcn4 [46]. In accordance, we observed that deletion of GCN4 provided some suppression to cdc28-E217V cells (Fig. 3E). As a final test we reexamined each of the Cks1-binding mutants for genetic interaction with FLO8. Interestingly less that half of these mutants were suppressed by deletion of FLO8 (Table 1). These observations indicate that the interaction of PKA through Flo8 with Cdc28 may be highly specific to a particular mechanism of CDK regulation.
###end p 31
###begin title 32
Swe1 is modulated by PKA and Cks1
###end title 32
###begin p 33
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8</italic>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPK2 </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
These results supported the Ras2-activated PKA pathway via Flo8 to be an important regulator of Cdc28. Previous genetic evidence by La Valle and Wittenberg suggested that Swe1 regulation of Cdc28 may be an effector of PKA [18]. Therefore, we directly tested if Swe1 function is modulated by the PKA pathway. We found that deletions of RAS2, FLO8, or the filamentous-growth specific PKA catalytic subunit TPK2 [47] in otherwise wild-type cells each diminished Cdc28 Tyr19 phosphorylation, placing the PKA signaling upstream of Swe1 and Cdc28 (Figure 5A).
###end p 33
###begin p 34
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PKA controls Swe1 regulation of Cdc28</bold>
###xml 39 42 39 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">swe1</italic>
###xml 104 114 104 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mih1, ras2</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tpk2</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flo8</italic>
###xml 181 184 175 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 194 211 188 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V swe1 </italic>
###xml 249 261 243 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 265 270 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">swe1 </italic>
###xml 301 304 289 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 318 335 306 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V swe1 </italic>
###xml 397 409 379 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 413 418 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">swe1 </italic>
PKA controls Swe1 regulation of Cdc28. A) Western blot analysis of Cdc28 Tyr19 phosphorylation in swe1, mih1, ras2, tpk2, flo8, or wild-type cells grown to log phase at 30degreesC. B) Growth of cdc28-E217V swe1 double mutants compared to wild-type, cdc28-E217V and swe1 cells at 25, 30 or 35degreesC. C) Morphology of cdc28-E217V swe1 double mutants at 25, 30 or 35degreesC compared to wild-type, cdc28-E217V and swe1 cells.
###end p 34
###begin p 35
###xml 63 75 63 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 189 201 189 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 207 212 207 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, C</xref>
###xml 344 356 344 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SIC1 </italic>
###xml 502 514 502 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Given the relationship between PKA and Swe1, we also tested if cdc28-E217V is modulated by SWE1. Strikingly, deletion of SWE1 conferred suppression of both growth and morphology defects of cdc28-E217V (Fig. 5B, C). Again, we asked if these effects were specific to Swe1 or if the absence of any negative regulator of CDK function would improve cdc28-E217V defects. Toward examining this question, we observed that deletion of the Cdc28 stoichiometic inhibitor SIC1 had only subtle effects on growth of cdc28-E217V cells [48].
###end p 35
###begin p 36
###xml 214 219 214 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">suc1 </sup>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MIH1 </italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1</italic>
One interpretation of these data is that Swe1 functions upstream of Cks1. Nonetheless, arguing against a role for Swe1 binding or Cdc28 Tyr19 phosphorylation in modulating Cks1 binding, Cdc28 was pulled down by p13suc1 beads to a similar extent from extracts of cells lacking SWE1 or its opposing phosphatase, MIH1 (Fig. 6A). An alternative explanation is that Cks1 antagonizes Cdc28 binding to or phosphorylation by Swe1. However, GST-Swe1 beads pulled down Cdc28-E217V and wild-type Cdc28 with similar levels, and independent of expression of high copy CKS1. In turn, increased Cdc28 Tyr19 phosphorylation was not detected in the mutant cells (data not shown). Together, these results argue against Swe1 and Cks1 binding competitively to Cdc28.
###end p 36
###begin p 37
###xml 38 50 38 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased Swe1 protein levels mediate <italic>cdc28-E217V </italic>defects</bold>
###xml 59 62 59 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 65 70 65 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1 </sup>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">swe1 </italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mih1 </italic>
###xml 205 208 205 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 283 295 283 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
Increased Swe1 protein levels mediate cdc28-E217V defects. A) p13Suc1 beads pull-downs of Tyr19-phosphorylated and unphosphorylated Cdc28 from protein extracts prepared from swe1 or mih1 deletion strains. B) Western blot analysis of Myc-tagged Swe1 protein levels from wild-type and cdc28-E217V cells grown to log phase at 25degreesC and shifted to 37degreesC, or kept at 25degreesC for 4 h.
###end p 37
###begin p 38
###xml 95 107 95 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 143 155 143 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDC55</italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 723 728 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 729 731 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 756 761 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
###xml 823 829 817 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 883 891 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A, B, C</xref>
An alternative link to Cks1 is that Swe1 protein might accumulate and/or persist abnormally in cdc28-E217V cells. Western blot analysis of the cdc28-E217V cells revealed accumulation of Myc epitope-tagged Swe1, which appeared as a range of apparent molecular weights, a pattern previously ascribed to Swe1 phosphorylation [49] (Fig. 6B). To further pursue a role for Cks1 in Swe1 function, we examined cells lacking CDC55, a protein phosphatase 2A (PP2A) regulatory subunit that promotes Swe1 degradation. cdc55 mutants contain elevated levels of Swe1 and show morphological defects including slow growth, elongated morphology and increased Cdc28 Tyr19 hyperphosphorylation at 16degreesC, which are relieved by deletion of SWE1 [50]. Strikingly, high copy CKS1 also strongly suppressed the growth and morphology defects of cdc55 mutants and reduced Cdc28 Tyr19 phosphorylation (Fig. 7A, B, C). These results suggest that Cks1 opposes Swe1 accumulation and inhibitory phosphorylation.
###end p 38
###begin p 39
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cks1 opposes Swe1 function in <italic>cdc55 </italic>mutants</bold>
###xml 45 48 45 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 59 62 59 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 156 161 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
###xml 178 181 172 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 212 218 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 280 285 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
Cks1 opposes Swe1 function in cdc55 mutants. A) Growth and B) Morphology of cdc55 mutants (W303 background) at 16 and 37degreesC transformed with high copy CKS1 or empty vector. C) Cdc28 Tyr19 phosphorylation in cdc55 deletion mutants (W303 background) transformed with high copy CKS1 or empty vector.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 414 426 414 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8 </italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFL1</italic>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEC1 </italic>
###xml 726 737 726 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flo8 </italic>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1018 1030 1018 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 1089 1093 1089 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO8</italic>
Ras2-mediated signaling has been well studied in filamentous growth. Despite this, the extent of crosstalk between the Ras2-MAPK and Ras2-PKA pathways is uncertain. Although traditionally thought of as parallel pathways [8], there has been some evidence that the Kss1 MAPK pathway may inhibit the PKA pathway [51] and that Flo8 and Tec1 participate in shared complexes at promoters [52]. Our results indicate that cdc28-E217V cells are modulated by the PKA pathway, most likely via FLO8 though the direct targets that mediate this interaction are yet to be established. Deletions of a second downstream component of PKA signaling, SFL1, or the Ras2-MAPK transcriptional effector TEC1 did not show any genetic interaction with cdc28-E217V. La Valle and Wittenberg have shown that deletion of SWE1 restores filamentous growth to flo8 PKA signaling mutants [18]. Our results extend these findings to suggest the PKA pathway regulates filamentous growth in part by activating Swe1 to phosphorylate Cdc28 Tyr19. Given that cdc28-E217V phenotypes partially depend upon the PKA pathway including FLO8, but not the MAPK cascade, we suggest that the regulation of Cdc28 by Swe1 and Cks1 is likely specifically mediated by PKA.
###end p 41
###begin p 42
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 816 828 816 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 138 143 <span type="species:ncbi:4932">yeast</span>
A paradigm for signaling cascades that culminate in activation of a CDK regulator has been previously observed in the response of haploid yeast to mating pheromone that galvanizes the Ste-MAPK cascade leading to activation of the MAPK Fus3 [53]. Fus3 positively regulates the CDK inhibitor Far1 directly by phosphorylation and indirectly by transcriptional regulation. In turn, Far1 negatively regulates Cln-associated Cdc28 complexes by inhibiting kinase activity and altering its localization [54-56]. Interestingly, Far1 is also subject to a negative feedback loop involving phosphorylation by Cln-associated Cdc28 that is thought to lead to ubiquitination and degradation of Far1 [57]. We have shown that PKA-signaling pathway via Flo8 regulates Swe1-mediated Cdc28 Tyr19 phosphorylation, and that SWE1 mediates cdc28-E217V phenotypes. Similarly to Far1, Swe1 is a known Cdc28 substrate [6,22]. Swe1 has been found to make direct contact with the hydrophobic patch of Clb2 initially stabilizing cyclin-Cdc28 complexes prior to its hyperphosphorylation [58], providing a mechanism for feedback inhibition analogous to that of Far1.
###end p 42
###begin p 43
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217 </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 197 209 197 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 232 244 232 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
cdc28-E217 cells exhibit increased levels of Swe1 protein. Complex post-translational modification of Swe1 leads to several different mobility species [49]. Interestingly, each form accumulates in cdc28-E217V cells, suggesting that cdc28-E217V cells are competent to mediate phosphorylation and ubiquitination of Swe1. This is supported by the observation that Cdc28-E217V exhibits normal kinase activity toward histone H1 and exhibits physical association with Swe1 comparable to wild type Cdc28.
###end p 43
###begin p 44
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
Many CDK substrates are subject to subsequent ubiquitination and proteasome-dependent degradation including cyclins, the stoichiometric inhibitor Sic1, and the securin Pds1 [59,60]. Ubiquitination of proteins is mediated by two complexes, the Skp1-cullin-F-box-protein complex (SCF) and the Anaphase-Promoting Complex (APC). Although SCF complex functions at multiple cell cycle transitions, the APC is thought to function only during mitosis. Substrate specificity of each of these complexes is determined in part by F-box subunits for the SCF, and WD-repeat containing proteins for the APC [26,61]. That the Cdc28-Cks1 physical interaction may be important in the downregulation of Swe1, a CDK substrate, suggests that one role of Cks1 may be to recruit the protein degradation machinery to CDK complexes. Such a role has been reported for the mammalian Cks1, which facilitates ubiquitination and degradation of p27, a CDK stoichiometric inhibitor [62].
###end p 44
###begin p 45
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
In yeast, Cks1 and Cdc28 have been reported to interact with the 26S proteasome [30]. Morris and Reed have proposed a model in which Cks1 recruitment of the proteasome and Cdc28 is important for displacement of CDK from specific promoters in a novel mechanism of transcriptional regulation [29,63]. Crystal studies of mammalian Cks1 have suggested that Cks1 exists as both a monomer and a multimer, although the regulation and function of this transition is not known [64]. Bourne and Tainer have suggested that Cks1 dimerization forms a pocket which may serve to shuttle phospho-proteins [64]. Further recent evidence has shown that Cks1 interacts directly with monoubiquitin and tetraubiquitin [65]. Together, these findings suggest that Cks1 may facilitate transition of ubiquitinated CDK substrates to the proteasome.
###end p 45
###begin p 46
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">met30 </italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 295 304 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET30</italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSL7</italic>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MIH1 </italic>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 685 691 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET30 </italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET4 </italic>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 371 376 <span type="species:ncbi:4932">yeast</span>
Understanding of events leading to Swe1 degradation however has proven elusive. Kaiser and Reed have shown that the SCF subunit Met30 interacts physically with Swe1 and that met30 mutants exhibit stabilization of Swe1 protein expressed from an inducible promoter [66]. It is also suggested that in vitro translated Swe1 exhibits lower mobility forms on exposure to whole yeast extract that are dependent on the presence of Met30 [66]. However, studies from the Lew laboratory have shown that deletion of MET30, unlike HSL7, does not enhance the filamentous phenotype caused by deletion of the opposing Tyr19 phosphatase MIH1 [22]. Further, they have also shown that double deletion of MET30 and another SCF subunit MET4 does not stabilize Swe1 protein levels. To further examine Swe1 regulation, McMillan and colleagues measured Cdc28 tyrosine phosphorylation in the absence of each of 13 deletions of non-essential F-box subunits, none of which showed an appreciable increase [22]. Finally, Kellogg has suggested that Swe1 protein is present throughout mitosis and that degradation may not be a primary mechanism of regulation [49,67]. Our findings support that Swe1 protein levels are subject to regulation that depends on Cks1.
###end p 46
###begin p 47
###xml 102 114 102 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 170 179 170 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2-V19 </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2 </italic>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDE2 </italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS2 </italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
That Cks1 may have a role in regulating protein stability may also explain the genetic interaction of cdc28-E217V with the PKA pathway. Bolte and Irniger have found that RAS2-V19 enhances the growth defects of mutants of the APC through a mechanism that depends on activation of adenylate cyclase [24]. Conversely, deletion of RAS2 or overexpression of PDE2 diminishes the growth defects of APC mutants. However, it has also been observed that deletion of RAS2 may have the opposite effect on SCF mutants, actually enhancing growth defects [25].
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 193 204 193 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V</italic>
###xml 357 369 357 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28-E217V </italic>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CKS1 </italic>
###xml 609 615 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc55 </italic>
###xml 149 154 <span type="species:ncbi:4932">yeast</span>
Our results indicate that the RAS-mediated PKA pathway and Cks1 are important regulators of Swe1 and, thereby, of Cdc28-Clb2 mitotic function during yeast filamentous growth. The phenotypes of cdc28-E217V, a mutant deficient for proper Cdc28-Cks1 association, are partly dependent on the presence of PKA pathway components and Swe1. Swe1 accumulates in the cdc28-E217V cells supporting prior studies showing that association of Swe1 with Clb2 mediates negative feedback provided by CDK phosphorylation [62]. Overexpression of CKS1 restores near wild-type growth, morphology and Cdc28 Tyr19 phosphorylation to cdc55 mutant cells defective for Swe1 degradation. Future studies elucidating the precise degradation machinery required for Swe1 turnover will be important in understanding the importance of the PKA pathway in regulating Cdc28 CDK activity.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
Strain construction
###end title 51
###begin p 52
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 38 43 <span type="species:ncbi:4932">yeast</span>
###xml 56 61 <span type="species:ncbi:4932">yeast</span>
###xml 160 165 <span type="species:ncbi:4932">Yeast</span>
Gene replacement, allele integration, yeast mating, and yeast transformation were as described [3,68]. For genetic analyses, multiple tetratypes were examined. Yeast strains were constructed in the Sigma 1278b background unless indicated. Strains and plasmids were derived from the following:
###end p 52
###begin title 53
Strains
###end title 53
###begin p 54
SKY750 - MATa/alpha cdc28::TRP1/cdc28::TRP1 his3 [pCT3 CDC28 URA3]; SKY768 - MATa clb1::TRP1 ura3; SKY772 - MATa clb2::LEU2 ura3; SKY901 - MATalpha swe1::LEU2 ura3; SKY903 - MATalpha mih1::LEU2 ura3; SKY985 - MATa cln1::URA3 cln2::LEU2 trp1; SKY2244 - MATalpha ura3 his3 leu2 trp1; SKY2256 - MATa/MATalpha ura3/ura3 his3/his3 leu2/LEU2 trp1/TRP1; SKY2264 - MATa ura3 his3; SKY2618 - MATa ras2::kanMX6 ura3 his3 leu2; SKY3003 - MATa/MATalpha cdc28-E217V:kanMX6/cdc28-E217V:kanMX6; SKY3004 - MATa/MATalpha CDC28/cdc28-E217V:kanMX6; SKY3005 - MATalpha cdc28-E217V:kanMX6 ura3 his3 leu2; SKY3006 - MATalpha SWE1-13Myc:kanMX6; SKY3007 - MATa flo8::kanMX6 ura3 his3 trp1; SKY3008 - MATalpha sfl1::kanMX6 his3; SKY3009 - MATalpha tec1:kanMX6 ura3 his3; SKY3010 - MATa tpk2::kanMX6 ura3 his3 leu2 trp1; SKY3011 - MATa cdc55::kanMX6 ura3 his3 trp1 (W303); SKY3012 - MATa gcn4::HIS3 ura3 leu2
###end p 54
###begin title 55
Plasmids
###end title 55
###begin p 56
###xml 21 34 21 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 &#956; URA3 GAL</italic>
###xml 79 98 78 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 &#956; URA3 GAL&gt;PTC2 </italic>
###xml 141 160 139 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 &#956; URA3 GAL&gt;PTC3 </italic>
###xml 200 214 197 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 &#956; URA3 CLB2</italic>
###xml 240 249 235 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 CAK1</italic>
###xml 274 283 268 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 CLN1</italic>
###xml 308 317 301 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 CKS1</italic>
###xml 342 346 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 364 378 356 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN URA3 CDC28</italic>
###xml 403 408 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 409 411 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 487 493 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 501 509 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN HIS3</italic>
pSKB4250 - YEplac195 2 mu URA3 GAL> (gift of M. Solomon); pSKB4251 - YEplac195 2 mu URA3 GAL>PTC2 (gift of M. Solomon); pSKB4252 - YEplac195 2 mu URA3 GAL>PTC3 (gift of M. Solomon); pSKB4253 - pRS202 2 mu URA3 CLB2; pSKB4254 - pRS 202 2 mu URA3 CAK1; pSKB4255 - pRS202 2 mu URA3 CLN1; pSKB4256 - pRS202 2 mu URA3 CKS1; pSKB4257 - pRS202 2 mu URA3; pSKB4258 - pCT3 CEN URA3 CDC28; pSKB4259 - pGEX-3x-GST-SWE1 [69] (gift of J. Thorner); pSKB4260 - pGEX-3x-GST (gift of J. Thorner); pRS413-cdc28 library CEN HIS3
###end p 56
###begin title 57
Screen for cdc28 mutants
###end title 57
###begin p 58
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 209 224 209 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN URA3 CDC28 </italic>
###xml 251 253 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 676 678 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
A degenerate-PCR derived library of cdc28 mutants cloned into pRS413 was used to transform SKY750 [3]. The transformants were then replica-plated onto 5-Fluoroorotic acid (5-FOA)-containing media to evict the CEN URA3 CDC28 plasmid. About 50,000 5-FOAR colonies were plated on synthetic low ammonia dextrose (SLAD) media. Five hundred colonies exhibiting enhanced filamentous growth were isolated and from these, 64 showed dramatically reduced growth at 35degreesC. Plasmids were rescued and re-introduced in SKY750. After 5-FOA treatment, 39 were found to confer a strong phenotype and were sequenced. Genomic integration of the E217V mutation into SKY2256 was as described [68]. Tetrad analysis and DNA sequencing were used to confirm the integration.
###end p 58
###begin title 59
Bioinformatic Analysis
###end title 59
###begin p 60
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
The effect of polymorphism at E217 was studied as described [38]. Molecular modeling was performed as described [3] using Swiss-Model and Swiss-PDB-Viewer [70,71].
###end p 60
###begin title 61
Spot Tests
###end title 61
###begin p 62
###xml 913 915 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 916 918 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast cultures were grown to saturation in rich or selective liquid media at 22degreesC. Saturated cultures were diluted serially at a ratio of 1/5 and spotted onto rich or selective agar medium. We have found the cdc28 mutants, possibly in part of because of the essential nature of many Cdc28 functions, have a tendency to acquire genomic and intragenic suppressor mutations. Because of this, we repeated spot testing at least four times for each experiment and a representative assay is shown. Each of the experimental groups shown within a given experiment were performed together on the same plate at each temperature. Images were acquired with a Pixera Professional camera on a Zeiss inverted microscope using brightfield illumination and contrast-enhanced in Adobe Photoshop. Magnification for detail of growth and morphology was performed in accord with previously published assessments of filamentation [72,73].
###end p 62
###begin title 63
Biochemical Analyses
###end title 63
###begin p 64
###xml 874 879 874 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1 </sup>
###xml 980 985 973 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1 </sup>
###xml 1309 1314 1301 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Suc1 </sup>
###xml 1358 1366 1350 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1401 1406 1393 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SWE1 </italic>
###xml 1407 1409 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1475 1479 1467 1471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 820 826 <span type="species:ncbi:9986">rabbit</span>
###xml 835 840 <span type="species:ncbi:10090">mouse</span>
###xml 1204 1209 <span type="species:ncbi:4932">yeast</span>
###xml 1358 1370 <span type="species:ncbi:511693">E. coli BL21</span>
Yeast extracts were prepared from log phase cultures by bead beating in buffer containing 50 mM Tris pH 7.6, 10% glycerol, 0.5% NP-40, 2 mM EDTA, 250 mM NaCl, 1 mM phenylmethylsulphonyl fluoride, and protease inhibitor cocktail (Roche). Protein content was determined by Bradford assay. For Western blot analysis, proteins separated by SDS-PAGE were transferred to nitrocellulose membranes, and blocked in TBS-Tween-20 containing 5% milk, or 5% BSA for anti-phospho-Tyr15 Cdc2 antibody (Cell Signaling Technologies). Membranes were probed with polyclonal anti-Myc (A14, Santa Cruz) at 1/1000 dilution, anti-PSTAIRE (Santa Cruz) at 1/500, anti-phospho-Tyr15 Cdc2 (Cell Signaling Technologies) at 1/1000, or anti-PGK (Molecular Probes) at 1/2500. Membranes were washed 3x with TBS-Tween-20 and probed with HRP-linked anti-rabbit or anti-mouse IgG (Amersham) at 1/2500. For p13Suc1 pull-down reactions, 1 mg of protein extract was incubated overnight at 4degreesC with 50 mu l of p13Suc1 Sepharose bead slurry (Upstate). Beads were washed five times with extract buffer, boiled in sample buffer and the supernatants subjected to SDS-PAGE. For binding assays using GST-Swe1 coated glutathione beads, 1 mg of yeast extract was incubated overnight with 100 mu l of 50% glutathione bead slurry and treated as for p13Suc1 Sepharose beads. GST-Swe1 was isolated from E. coli BL21(DE3) plysS harboring pGEX-GST-SWE1 [69], a kind gift from Jeremy Thorner. Bacteria were grown to an O.D.600 of 0.6, induced for 3 h at 37degreesC with 0.2 mM IPTG, and briefly sonicated in PBS buffer containing protease inhibitor cocktail, 1 mM PMSF, 1 mM Orthovanadate, 0.5 mM DTT, and 1% Triton X-100. Glutathione beads were incubated with 1-2 mg of protein extract overnight at 4degreesC. GST-Swe1 coated beads were washed five times with PBS and incubated with extracts.
###end p 64
###begin title 65
Abbreviations
###end title 65
###begin p 66
(CDK): cyclin-dependent kinase; (SCF): Skp1-cullin-F-box-protein complex; (PKA): protein kinase A; (MAPK): mitogen-activated protein kinase; (PP2A): protein phosphatase 2A; (G1): growth phase 1; (S): synthesis phase; (G2): growth phase 2; (M): mitosis.
###end p 66
###begin title 67
Competing interests
###end title 67
###begin p 68
The authors declare that they have no competing interests.
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 731 737 731 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
###xml 907 913 907 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc28 </italic>
BT generated the hypotheses and conclusions presented and conducted the genetic and biochemical experiments as well as wrote the manuscript. AK made significant contributions to the conception, design, hypotheses and interpretation of data of all of the studies presented, provided substantial technical assistance and optimization of genetic and biochemical assays, developed a large proportion of the specific reagents for testing of genetic and biochemical interactions of cell cycle genes, and extensively reviewed and revised the manuscript. JS and RG participated in repeating and confirming experimental results, as well as compilation and organization of the data. BB performed the primary screen for temperature sensitive cdc28 alleles. JC provided intellectual contributions, technical support and aided in review and revision of the manuscript. DC conducted bioinformatic analyses of each of the cdc28 alleles. SK conceived the initial study, directed and coordinated all studies, and provided resources and materials for the studies presented.
###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
We thank S. Anderson, B. Nacev, M. Rengarajan, S. Ahn, A. Javaheri, J. Fitz Gerald, S. Palecek, D. Rua, D. Lew, M. Solomon, and J. Thorner for generously providing strains, reagents and expertise. This work was supported by NSF grant MCB 9875976, NIH grant GM60443 and a Leukemia and Lymphoma Society Scholar award to SJK; and NSF grant RIG 0718442 to AAK. BTDT was a trainee of the U. Chicago NIH MST Program and funded by a pre-doctoral grant from the American Heart Association.
###end p 72
###begin article-title 73
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
A cell cycle checkpoint monitors cell morphogenesis in budding yeast
###end article-title 73
###begin article-title 74
###xml 94 99 <span type="species:ncbi:4932">yeast</span>
Regulation of G2/M progression by the STE mitogen-activated protein kinase pathway in budding yeast filamentous growth
###end article-title 74
###begin article-title 75
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Enhanced cell polarity in mutants of the budding yeast cyclin-dependent kinase Cdc28p
###end article-title 75
###begin article-title 76
###xml 66 90 66 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 60 65 <span type="species:ncbi:4932">yeast</span>
###xml 66 90 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Characterization of four B-type cyclin genes of the budding yeast Saccharomyces cerevisiae
###end article-title 76
###begin article-title 77
###xml 96 120 96 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 90 95 <span type="species:ncbi:4932">yeast</span>
###xml 96 120 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae
###end article-title 77
###begin article-title 78
Targets of the cyclin-dependent kinase Cdk1
###end article-title 78
###begin article-title 79
###xml 58 82 58 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 58 82 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Characterization of alcohol-induced filamentous growth in Saccharomyces cerevisiae
###end article-title 79
###begin article-title 80
###xml 116 140 116 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 116 140 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Crosstalk between the Ras2p-controlled mitogen-activated protein kinase and cAMP pathways during invasive growth of Saccharomyces cerevisiae
###end article-title 80
###begin article-title 81
###xml 37 61 37 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 37 61 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Control of pseudohyphae formation in Saccharomyces cerevisiae
###end article-title 81
###begin article-title 82
###xml 33 57 33 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
###xml 33 57 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
MAP kinase pathways in the yeast Saccharomyces cerevisiae
###end article-title 82
###begin article-title 83
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae TEC1 </italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae TEC1 is required for pseudohyphal growth
###end article-title 83
###begin article-title 84
###xml 10 15 <span type="species:ncbi:4932">yeast</span>
The three yeast A kinases have specific signaling functions in pseudohyphal growth
###end article-title 84
###begin article-title 85
###xml 58 63 <span type="species:ncbi:4932">yeast</span>
Protein kinase A operates a molecular switch that governs yeast pseudohyphal differentiation
###end article-title 85
###begin article-title 86
###xml 31 37 <span type="species:ncbi:4932">yeasts</span>
###xml 76 81 <span type="species:ncbi:4932">yeast</span>
Domains of the SFL1 protein of yeasts are homologous to Myc oncoproteins or yeast heat-shock transcription factor
###end article-title 86
###begin article-title 87
###xml 86 110 86 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 86 110 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae
###end article-title 87
###begin article-title 88
###xml 76 100 76 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 76 100 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cloning and characterization of the high-affinity cAMP phosphodiesterase of Saccharomyces cerevisiae
###end article-title 88
###begin article-title 89
Phosphorylation-independent inhibition of Cdc28p by the tyrosine kinase Swe1p in the morphogenesis checkpoint
###end article-title 89
###begin article-title 90
###xml 67 91 67 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 67 91 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A role for the Swe1 checkpoint kinase during filamentous growth of Saccharomyces cerevisiae
###end article-title 90
###begin article-title 91
###xml 14 39 14 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 14 38 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Properties of Saccharomyces cerevisiae Wee1 and its differential regulation of p34CDC28 in response to G1 and G2 cyclins
###end article-title 91
###begin article-title 92
###xml 38 43 <span type="species:ncbi:9606">human</span>
High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design
###end article-title 92
###begin article-title 93
Cdk1-dependent regulation of the mitotic inhibitor Wee1
###end article-title 93
###begin article-title 94
###xml 37 61 37 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 37 61 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Determinants of Swe1p degradation in Saccharomyces cerevisiae
###end article-title 94
###begin article-title 95
###xml 32 56 32 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 32 56 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The morphogenesis checkpoint in Saccharomyces cerevisiae: cell cycle control of Swe1p degradation by Hsl1p and Hsl7p
###end article-title 95
###begin article-title 96
###xml 120 144 120 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 120 144 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Synergistic inhibition of APC/C by glucose and activated Ras proteins can be mediated by each of the Tpk1-3 proteins in Saccharomyces cerevisiae
###end article-title 96
###begin article-title 97
###xml 74 98 74 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 74 98 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Glucose and ras activity influence the ubiquitin ligases APC/C and SCF in Saccharomyces cerevisiae
###end article-title 97
###begin article-title 98
APC/C and SCF: controlling each other and the cell cycle
###end article-title 98
###begin article-title 99
###xml 31 47 31 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCC1/MCD1/RHC21 </italic>
###xml 12 17 <span type="species:ncbi:4932">yeast</span>
The budding yeast cohesin gene SCC1/MCD1/RHC21 genetically interacts with PKA, CDK and APC
###end article-title 99
###begin article-title 100
Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase-promoting complex
###end article-title 100
###begin article-title 101
###xml 87 92 <span type="species:ncbi:4932">yeast</span>
Cks1-dependent proteasome recruitment and activation of CDC20 transcription in budding yeast
###end article-title 101
###begin article-title 102
###xml 69 74 <span type="species:ncbi:4932">yeast</span>
Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets
###end article-title 102
###begin article-title 103
###xml 63 87 63 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 63 87 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The Cdk-associated protein Cks1 functions both in G1 and G2 in Saccharomyces cerevisiae
###end article-title 103
###begin article-title 104
###xml 77 82 <span type="species:ncbi:4932">yeast</span>
Cks1 is required for G(1) cyclin-cyclin-dependent kinase activity in budding yeast
###end article-title 104
###begin article-title 105
Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine
###end article-title 105
###begin article-title 106
The dynamics of cyclin dependent kinase structure
###end article-title 106
###begin article-title 107
Crystal structure of cyclin-dependent kinase 2
###end article-title 107
###begin article-title 108
Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors
###end article-title 108
###begin article-title 109
###xml 49 54 <span type="species:ncbi:9606">human</span>
Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1
###end article-title 109
###begin article-title 110
Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation
###end article-title 110
###begin article-title 111
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2
###end article-title 111
###begin article-title 112
###xml 34 59 34 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 34 58 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Activating phosphorylation of the Saccharomyces cerevisiae cyclin-dependent kinase, Cdc28p, precedes cyclin binding
###end article-title 112
###begin article-title 113
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases
###end article-title 113
###begin article-title 114
Dephosphorylation of cyclin-dependent kinases by type 2C protein phosphatases
###end article-title 114
###begin article-title 115
###xml 72 96 72 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 72 96 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Signal transduction cascades regulating pseudohyphal differentiation of Saccharomyces cerevisiae
###end article-title 115
###begin article-title 116
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast pseudohyphal growth is regulated by GPA2, a G protein alpha homolog
###end article-title 116
###begin article-title 117
###xml 83 108 83 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 83 107 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Gpa2p, a G-protein alpha-subunit, regulates growth and pseudohyphal development in Saccharomyces cerevisiae via a cAMP-dependent mechanism
###end article-title 117
###begin article-title 118
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FLO11 </italic>
###xml 86 110 86 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 86 110 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Amino acid starvation and Gcn4p regulate adhesive growth and FLO11 gene expression in Saccharomyces cerevisiae
###end article-title 118
###begin article-title 119
###xml 78 102 78 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 78 102 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae
###end article-title 119
###begin article-title 120
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
The cyclin-dependent kinase inhibitory domain of the yeast Sic1 protein is contained within the C-terminal 70 amino acids
###end article-title 120
###begin article-title 121
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Conservation of mechanisms controlling entry into mitosis: budding yeast wee1 delays entry into mitosis and is required for cell size control
###end article-title 121
###begin article-title 122
Loss of a protein phosphatase 2A regulatory subunit (Cdc55p) elicits improper regulation of Swe1p degradation
###end article-title 122
###begin article-title 123
A novel functional link between MAP kinase cascades and the Ras/cAMP pathway that regulates survival
###end article-title 123
###begin article-title 124
Recruitment of the Swi/Snf complex by Ste12-Tec1 promotes Flo8-Mss11-mediated activation of STA1 expression
###end article-title 124
###begin article-title 125
Pheromone response, mating and cell biology
###end article-title 125
###begin article-title 126
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1
###end article-title 126
###begin article-title 127
###xml 35 60 35 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 35 59 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cln3-associated kinase activity in Saccharomyces cerevisiae is regulated by the mating factor pathway
###end article-title 127
###begin article-title 128
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Pheromone-dependent G1 cell cycle arrest requires Far1 phosphorylation, but may not involve inhibition of Cdc28-Cln2 kinase, in vivo
###end article-title 128
###begin article-title 129
###xml 111 116 <span type="species:ncbi:4932">yeast</span>
Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast
###end article-title 129
###begin article-title 130
###xml 78 102 78 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 78 102 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Identification of Clb2 residues required for Swe1 regulation of Clb2-Cdc28 in Saccharomyces cerevisiae
###end article-title 130
###begin article-title 131
###xml 33 57 33 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 33 57 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Rpn6p, a proteasome subunit from Saccharomyces cerevisiae, is essential for the assembly and activity of the 26 S proteasome
###end article-title 131
###begin article-title 132
Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase
###end article-title 132
###begin article-title 133
SCF and APC: the Yin and Yang of cell cycle regulated proteolysis
###end article-title 133
###begin article-title 134
A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1
###end article-title 134
###begin article-title 135
A kinase-independent function of Cks1 and Cdk1 in regulation of transcription
###end article-title 135
###begin article-title 136
###xml 49 74 49 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 49 73 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Crystal structure and mutational analysis of the Saccharomyces cerevisiae cell cycle regulatory protein Cks1: implications for domain swapping, anion binding and protein interactions
###end article-title 136
###begin article-title 137
###xml 44 49 <span type="species:ncbi:4932">yeast</span>
The alpha helix of ubiquitin interacts with yeast cyclin-dependent kinase subunit CKS1
###end article-title 137
###begin article-title 138
Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1
###end article-title 138
###begin article-title 139
Wee1-dependent mechanisms required for coordination of cell growth and cell division
###end article-title 139
###begin article-title 140
###xml 65 70 <span type="species:ncbi:4932">yeast</span>
Marker-fusion PCR for one-step mutagenesis of essential genes in yeast
###end article-title 140
###begin article-title 141
###xml 59 94 59 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae cell cycle</italic>
###xml 59 83 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Dynamic localization of the Swe1 regulator Hsl7 during the Saccharomyces cerevisiae cell cycle
###end article-title 141
###begin article-title 142
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling
###end article-title 142
###begin article-title 143
SWISS-MODEL: An automated protein homology-modeling server
###end article-title 143
###begin article-title 144
###xml 46 71 46 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 46 70 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Regulators of pseudohyphal differentiation in Saccharomyces cerevisiae identified through multicopy suppressor analysis in ammonium permease mutant strains
###end article-title 144
###begin article-title 145
###xml 54 59 <span type="species:ncbi:4932">yeast</span>
Combinatorial control required for the specificity of yeast MAPK signaling
###end article-title 145

